Evidence map›Paper›PMID 37124973›Full record

ArticleWorld journal of cardiology2023

Right ventricle dysfunction does not predict mortality in patients with SARS-CoV-2-related acute respiratory distress syndrome on extracorporeal membrane oxygenation support.

Chiara Lazzeri, Manuela Bonizzoli, Stefano Batacchi, Giovanni Cianchi, Andrea Franci, Filippo Socci, Marco Chiostri, Adriano Peris

Open access · diamondAbstract read
In one paragraph

Article in World journal of cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Chiara LazzeriICU and ECMO Center, Florence 50134, Italy. lazzeri.ch@gmail.com.
Manuela BonizzoliICU and ECMO Center, Florence 50134, Italy.
Stefano BatacchiICU and ECMO Center, Florence 50134, Italy.
Giovanni CianchiICU and ECMO Center, Florence 50134, Italy.
Andrea FranciICU and ECMO Center, Florence 50134, Italy.
Filippo SocciICU and ECMO Center, Florence 50134, Italy.
Marco ChiostriICU and ECMO Center, Florence 50134, Italy.
Adriano PerisICU and ECMO Center, Florence 50134, Italy.
University of Florence · ITGrado Zero Espace (Italy) · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe prognostic role of right ventricle dilatation and dysfunction (RVDD) has not been elucidated in patients with coronavirus disease (COVID)-related respiratory failure refractory to standard treatment needing extracorporeal membrane oxygenation (ECMO) support.

aimTo assess whether pre veno-venous (VV) ECMO RVDD were related to in-intensive care unit (ICU) mortality.

methodsWe enrolled 61 patients with COVID-related acute respiratory distress syndrome refractory to conventional treatment submitted to VV ECMO and consecutively admitted to our ICU (an ECMO referral center) from 31

resultsMales were prevalent (73.8%) and patients with a body mass index > 30 kg/m

conclusionIn patients with COVID-related respiratory failure on ECMO support, RVDD (dilatation and dysfunction) is a common finding and identifies a subset of patients characterized by a more severe disease (as indicated by higher SOFA values and need of renal replacement therapy) and by a higher in-ICU mortality. RVDD (also when considered separately) did not result independently associated with in-ICU mortality in these patients.

Indexed as

Acute respiratory distress syndromeCOVIDEchocardiographyMortalityRight ventricleRight ventricle-pulmonary circulation coupling

Identifiers

PMID37124973
PMCPMC10130894
OpenAlexW4366541955

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.